3 Best Marijuana Stocks in November — Are They Buys Now?

November is nothing but a memory now. For many cannabis-focused investors, that’s a good thing. Most marijuana stocks again delivered dismal results last month.

But three marijuana stocks performed quite well in November…

Curaleaf Holdings (OTC:CURLF)Trulieve Cannabis (OTC:TCNNF), and Green Thumb Industries (OTC:GTBIF) chalked up strong double-digit percentage gains. Here’s how these three stocks succeeded while most of their peers floundered — and whether they’re smart picks to buy now.

1. Curaleaf

Shares of Curaleaf soared nearly 30% last month. The primary reason for the strong performance was the U.S.-based cannabis operator’s really great third-quarter results.

Curaleaf reported all-time high revenue in Q3 of $61.8 million, up a whopping 189% year over year. Several factors fueled this impressive growth. The company’s medical cannabis sales picked up in the important Florida and New York markets. Curaleaf also received a revenue boost from its acquisitions in Arizona and Maryland.

While those sizzling Q3 results served as the biggest catalyst for Curaleaf, the company also achieved several other key milestones in November that made investors happy. Early in the month, Curaleaf opened its first dispensary targeting Massachusetts’ adult-use recreational marijuana market. The company also expanded its Florida operations, opening new medical cannabis dispensaries in Jensen Beach and Sarasota.

2. Trulieve

Trulieve wasn’t too far behind Curaleaf, with its shares jumping 26% in November. And if you liked Curaleaf’s Q3 update, you’ll also like Trulieve’s Q3 results, which my colleague Sean Williams referred to as “the best marijuana earnings report of the entire quarter.”

While Trulieve posted impressive sales figures in the third quarter — revenue skyrocketed 150% year over year and 22% quarter over quarter to $70.7 million — the really great news for the company was on its bottom line. Trulieve reported Q3 net income of $60.3 million, with adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $36.9 million.

The company continues to dominate Florida’s medical cannabis market. Trulieve recently became the first cannabis operator in the state to open its 40th dispensary. At the end of 2016, the company had only two medical cannabis dispensaries in Florida…

Continue reading at THE MOTLEY FOOL

You May Also Like

About the Author: admin

Leave a Reply

Your email address will not be published.